Navigation Links
Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
Date:10/5/2007

BOSTON, Oct. 5 /PRNewswire/ -- Surface Logix, Inc. today announced the presentation of positive safety and efficacy data from its innovative Phase 1 repeat-dose clinical trial of its investigational drug candidate SLx-4090, a first-in-class enterocyte-specific microsomal triglyceride transfer protein (MTP) inhibitor being developed for the treatment of dyslipidemia (abnormal levels of lipids in the bloodstream). The data indicated not only that repeat- dosing at all dose levels of SLx-4090 was well tolerated, with no serious adverse events reported, but also that SLx-4090 significantly decreased plasma levels of both triglyceride and LDL-cholesterol compared to placebo. These data extend earlier findings previously reported from a single-dose study relating to the safety, tolerability and pharmacokinetic and pharmacodynamic profiles of SLx-4090. Results were presented at the 16th International Symposium on Drugs Affecting Lipid Metabolism being held October 4-7 in New York, NY.

"It is exciting that this novel compound continued to perform so well in this first repeat-dose study," said Dr. William Prince, Chief Development Officer of Surface Logix. "Consistent with our preclinical and Phase 1 single-dose results, no drug was detected in the plasma at doses up to 200 mg given three times daily for two weeks. This is particularly notable, as all other known MTP inhibitors have been shown to enter the systemic circulation and negatively impact standard measures of liver function. SLx-4090 was extremely well tolerated and adverse events were similar to those seen with placebo."

"Based on the results of this study, we have advanced SLx-4090 into a Phase 2a study, which will be completed shortly, and initial results are confirming the profile seen in both Phase 1 studies," said Jim Mahoney, President and Chief Executive Officer of Surface Logix. "We are also planning to start a Phase 2b study in patients with dyslipidemia in the middle of 2008. Based on
'/>"/>

SOURCE Surface Logix, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference
2. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
10. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...ewswire/ -- BioTrends Research Group, Inc. release...report, the first in a multi-phase syndicated mark...r Ortho-Biotech,s Stelara, from product launch thr...ave of the report provides quantitative informatio...formation from a subset of 20. The reports assess...
(Date:11/25/2009)...ov. 25 AMPAC Fine Chemicals LLC (A...(Nasdaq: APFC ) announced today that it received ...y Award at the Annual Statewide Environmental Summ...Technology Association (CMTA), the Industrial Envi...try Council of California (CICC) held in San Diego...
(Date:11/25/2009)...PRNewswire/ -- Reportlinker.com announces that a n...logue: ,, Mammography Equipment - A Global Ma...com/p0164330/Mammography-Equipment---A-Global-Mark...ast cancer in industrialized as well as developing...in the mammography market. Globally, escalating aw...
Breaking Medicine Technology:Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8Orthopaedic Surgeon and AOSSM President Dr James Andrews to Discuss Injury Prevention 61098 1Orthopaedic Surgeon and AOSSM President Dr James Andrews to Discuss Injury Prevention 61098 2Orthopaedic Surgeon and AOSSM President Dr James Andrews to Discuss Injury Prevention 61098 3Sigma Aldrich 28Nasdaq 3A SIAL 29 Declares Quarterly Dividend 14787 1Cholesterol Measurements May Be Made Easier 61096 1Cholesterol Measurements May Be Made Easier 61096 2
...ov. 20 The following statement,was released today...an of,the Committee for Pro-Life Activities at the...Studies published this week in the journals Cell a...research and therapies while fully respecting,the ...Wisconsin used four genes to ,reprogram,ordinary a...
...kespeople to Drive Young People to Do Something Ra... WASHINGTON, Nov. 20 Look out for the Kick Me,sig...nd the nation.,YouthAIDS, an action-based initiati...l (PSI), today announced the launch of the 2007 ,K...hildish prank and turns it into,a powerful tool to...
Other Medicine Technology:Stem Cell Breakthrough Advances Science Without 'Ethical Landmines,' Says Cardinal 2YouthAIDS, Levi's and BET's Rap It-Up Campaign Kick Off 2007 'Kick Me' Campaign to Raise HIV/AIDS Awareness at High Schools, Colleges and Universities Across the Country 2YouthAIDS, Levi's and BET's Rap It-Up Campaign Kick Off 2007 'Kick Me' Campaign to Raise HIV/AIDS Awareness at High Schools, Colleges and Universities Across the Country 3
(Date:11/27/2009)...swire-FirstCall/ -- The Gymboree Corporation (Nasd... will present at the NASDAQ OMX 23rd Investor Prog...ondon, England, on Wednesday, December 2, 2009, at...st of The Gymboree Corporation,s presentation over...click on "Our Company" at the bottom of the page, ...
(Date:11/27/2009)...hicles may reduce future disease burden, researche...ws) -- Encouraging city dwellers to walk and bicyc...public health benefits than increased used of low-..., The study compared the projected health effects...rios for London, England, and Delhi, India: busin...
(Date:11/27/2009)...ufacturers who use medical load cells at the heart...by bringing in technology partner Flintec early in...ive medical manufacturers are calling in Flintec l...jects, ensuring that progress will not be constrai...tdated technology. , (PRW...
(Date:11/26/2009)...molybdate (TM) has been shown in studies to be eff...se caused by an overload of copper, and certain me... however, is known about how the drug works at the...ern University researchers now has provided an inv...M bound to copper-loaded metallochaperones. The dr...
(Date:11/26/2009)...gle Dental (RTDental), a leading dental group prac...e expansion of its services to include LUMINEERS b.... , Durham, NC (PRWEB)...e that Dr. Doug Macmillan, an experienced LUMINEE...nced training seminar. RTDental’s ability t...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2
...night outside Apple electronics stores in US citie...ed as the coolest gadget on the planet, when they ..., which puts a phone, web browser and music player...dful with pup tents and lawn chairs -- braved the ...
...shs Gorakhpur District are grappling to fight agai...s , that has killed at least 30 children in the pa...iatric Department, B.R.D Medical College, said tha...M.P.Singh, Joint-Director of state's health depart...
...mmission investigating the plight of the soldiers ...tan has focused on efforts to enable the GIs recei...uring its seventh and last hearing Friday, the Com...l from explosives, making their treatment more com...
...of anthropologists have embarked on a project to s...ed by anthropology professor Gerald Roche, the vol... aims at digitalizing and archiving all the songs ... want to record as many songs as possible," said D...
...NI): A new study has found that women with at leas... are nearly eight times more likely than average w...rlier studies have shown that atypical hyperplasia...idered at high risk. Many are adviced to c...
...erised screening test for cervical cancer detects ... , according to a study published on bmj.com today...g to be re-tested and might allow for longer inter...en around for decades but liquid-based cytology (L...
Other Medicine News:Health News:Tech Heads Go Gaga Waiting for Apple's IPhone 2Health News:Presidential Commission Wants Proper Care of Wounded Soldiers at Their Homes 2Health News:Digital Music Project Aims to Save Tibetan Folk Songs from Extinction 2Health News:Women With Atypia Nearly Eight Times More Likely to Develop Breast Cancer 2Health News:New Cervical Cancer Test Increases the Detection Rate of Abnormal Cells 2
...vascular ultrasound system provides dedicated and ..., all-digital ultrasound system offering exception...sensitivity and spatial resolution everything you...r products. Designed specifically for busy cardio...
AngioSpeed VH
Atlantis SR Plus Catheter
CardioGen-82®
Medicine Products: